Social Media Ideas for Glp-1 Ras (Drug)

Real-world findings suggest GLP-1 drugs offer health benefits for young people with diabetes

New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, from Sept. 28–Oct. 2 examined the real-world use of GLP-1...

GLP-1s: Still Early In The Growth Story

Limiting Weight Regain After GLP-1s: Two Strategies Show Promise

WEDNESDAY, Oct. 7, 2026 — What’s the best way to keep the scale from creeping back up after you stop using a GLP-1 medication? A study published today in the journal Obesity Scien...

GLP-1 Receptor Agonists and Diabetic Foot Ulcers

GLP-1 Receptor Agonists Are Associated With Reduced Mortality Following Diabetic Foot Ulcers: A Nationwide Observational Study Jean-Baptiste Bonnet et al Diabetes Care. 2026 Jan 30...

This New Drug Could Solve the GLP-1 Plateau Problem

Roche’s experimental enicepatide reduced weight without a plateau through week 48 while also improving blood sugar in adults with diabetes and obesity.

GLP-1s Show Benefit For Kids With Type 2 Diabetes

FRIDAY, Oct 2, 2026 — A real-world study finds GLP-1 medications helped kids, teens and young adults with type 2 diabetes lose weight, as well as improve their blood pressure and b...

Lilly’s Retatrutide GLP-1 Delivers Average Weight Loss of 50 Pounds

The experimental drug is not FDA-approved, and its biologic classification could shape when lower-cost competitors reach patients if regulators approve it.

GLP-1 Drugs Linked to Fewer Heart Complications and Infections After Surgery, New Study Finds

A new study of more than 2 million surgical patients found that those taking GLP-1 medications had lower odds of serious heart complications and infections after surgery. The findi...

GLP-1 Drugs and Joint Replacement: A 90-Day Signal Surgeons Can’t Ignore

Pre-op use of GLP-1 receptor agonists was associated with significantly improved total joint arthroplasty outcomes and risk reduction.

New Class Of Weight-Loss Drugs May Have Fewer Side Effects Than GLP-1s

MONDAY, Oct. 5, 2026 — An emerging class of weight-loss medications helps users shed pounds but with a much lower risk for gastrointestinal side effects compared to popular GLP-1s,...

Amylin analogs in the clinic: a deep dive 

Amylin analogs are in clinical trials to address metabolic diseases on their own as well as to enhance the effects of GLP-1 drugs. The post Amylin analogs in the clinic: a deep d...

As GLP-1s reshape America, questions and new uses emerge

Hailed by some as miracle drugs, GLP-1s have surged in popularity in the past few years. An estimated one out of every eight Americans is now on some version of them and scientists...

Finally, Some Evidence Employers Can Use to Justify Covering GLP-1s

Finally, Some Evidence Employers Can Use to Justify Covering GLP-1s Anonymous (not verified) Thu, 08/27/2026 - 09:40 pharmagather item url Finally, Some Ev...

Post-bariatric surgery weight loss appears unimpeded by GLP-1 use

Preoperative GLP-1 receptor agonist use did not impact bariatric surgery outcomes, including weight loss at 1 year, diabetes control and postsurgical complications, according to a...

Could GLP-1 drugs be anti-aging medications?

By Brenda Goodman, CNN (CNN) — GLP-1 medications for weight loss and diabetes appear to slow the body’s aging processes, a sign that the blockbuster drugs could ultimately help peo...

<![CDATA[Where GLP-1 Development May be Headed]]>

GLP-1 Use Surging Among New Mothers

FRIDAY, Oct. 2, 2026 — More women are now being prescribed GLP-1 medications like Ozempic and Zepbound after giving birth. A new study finds GLP-1 use among new mothers jumped from...

GLP-1 compounder issues recall for copycat Zepbound

The notice adds to growing concerns about the safety of knockoff weight loss drugs, which have remained popular despite FDA warnings and legal pressure from Eli Lilly and Novo.

The Hidden Risk of GLP-1 Drugs for Older Adults: Losing Weight Is Not the Same as Staying Healthy

The Hidden Risk of GLP-1 Drugs for Older Adults: Losing Weight Is Not the Same as Staying Healthy Anonymous (not verified) Wed, 10/21/2026 - 22:16 pharmagather item url...

People with Type 2 diabetes lost up to 60 pounds on Lilly's latest weight loss drug

Eli Lilly’s highly anticipated GLP-1 drug retatrutide helped people with Type 2 diabetes lose up to 60 pounds, or about 23% of their body weight, according to late-stage trial resu...

Unexpected GLP-1 side effect? Studies show the meds may help people with addictions

From unexpected babies to "Ozempic teeth," the ultra-popular class of GLP-1 medications are turning out to have a few unanticipated side effects. Emerging research shows the drugs,...

<![CDATA[The Most Surprising Development in GLP-1s]]>

GLP-1s linked to nutritional deficiencies in children

Children prescribed GLP-1 medications for weight loss, prediabetes or type 2 diabetes are at risk for nutritional deficiencies—diagnosed in nearly one in six patients (16.8%) withi...

Are GLP-1s the new statins?

Cardiologists are working the weight-loss drugs into more patient conversations.